Timeline (Bioavailability) of Magnesium Compounds in Hours: Which Magnesium Compound Works Best?
Level 5 - mechanism / opinion, no new human data
Preclinical animal research in Sprague Dawley rats
PubMed 29679349 · doi:10.1007/s12011-018-1351-9
What was done
Researchers evaluated the bioavailability, tissue distribution, and behavioral effects of five magnesium formulations (magnesium sulfate, magnesium oxide, magnesium acetyl taurate, magnesium citrate, and magnesium malate) in Sprague Dawley rats following a single dose of 400 mg/70 kg. Outcomes evaluated from the abstract were time-dependent absorption kinetics (area under the curve), tissue penetration (including brain), and anxiety-related behavioral indicators compared to a control group.
What was found
The abstract reports relative pharmacokinetic comparisons without numerical figures or statistical parameters: - Magnesium malate demonstrated the highest area under the curve (AUC) and remained elevated in serum for an extended duration. - Magnesium acetyl taurate had the second-highest AUC, was rapidly absorbed, achieved the highest concentration in brain tissue, and was associated with decreased anxiety indicators. - Magnesium oxide and magnesium citrate showed the lowest bioavailability relative to the control group.
Why it matters
This study suggests that chemical formulation significantly influences magnesium absorption kinetics and tissue-specific deposition, with acetyl taurate targeting brain tissue and malate providing extended systemic exposure.
Limits
Findings are derived entirely from a single-dose rodent model and cannot be directly extrapolated to human pharmacokinetics or clinical efficacy. The abstract reports no sample size (n), quantitative concentration measurements, variance, or specific details of the behavioral testing protocols.
Cited by
- supports Magnesium acetyl taurate crosses the blood-brain barrier.